122.29MMarket Cap-6493P/E (TTM)
4.130High3.960Low17.73KVolume3.960Open4.010Pre Close71.77KTurnover0.11%Turnover RatioLossP/E (Static)29.61MShares20.72052wk High40.49P/B68.33MFloat Cap3.51052wk Low--Dividend TTM16.54MShs Float20.720Historical High--Div YieldTTM4.24%Amplitude3.510Historical Low4.047Avg Price1Lot Size
Telomir Pharmaceuticals Stock Forum
NEWS
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.
Telomir Pharmaceuticals presents promising pre-clinical data on Telomir-1 at a National Press Club event, showcasing a 40% increase in telomerase activity and lengthening of telomeres in human cells. The company plans to initiate human clinical trials for osteoarthritis and veterinary trials in 2025 after pre-clinical...
No comment yet